Spruce Street Capital
Spruce Street Capital is a VC fund. It joined 1 round tracked by OSH in the last 90 days.
What they look for
Not published yet. OSH fills this in from Spruce Street Capital's own site, or from its deals once OSH tracks them.
Activity
Deals, 90 days
1
Deals, 12 months
1
Led, 12 months
0
Median disclosed round
$173M
Frequent co-investors:Scion Life SciencesVenbio PartnersOrbiMedRTW InvestmentsSurveyor Capital
Portfolio from OSH Rounds
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| $173M | Series B | Scion Life Sciences, Venbio Partners, OrbiMed | RTW Investments +7 | — | 1 |
Nov 17 · Series B
Marrow Therapeutics$173MLed by Scion Life Sciences, Venbio Partners, OrbiMed · with RTW Investments, +7
Questions and answers
How active is Spruce Street Capital?
In OSH Rounds, Spruce Street Capital joined 1 round in the last 90 days and 1 in the last 12 months, leading 0.
Sources
- 1.Sickle Cell Drug: Marrow Raises $173 Million Without Releasing Anemia or Selectivity Data — techtimes.com, Nov 17, 2026